Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cell Death and Differentiation|August 18, 2021
Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infectionMarcello Allegretti, Maria Candida Cesta, Mara Zippoli, et al.Life (Basel, Switzerland)|September 28, 2024
Retrospective Analysis of the Effect of Postmenopausal Women Medications on SARS-CoV-2 Infection ProgressionVeronica Cocetta, Manuel Zorzi, Stefano Bejor, et al.Nanoscale|December 16, 2014
Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivoAlessandra Quarta, Davide Bernareggi, Fabio Benigni, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 29, 2026
Raloxifene and tamoxifen reshape the immunometabolic phenotype of TLRs-activated macrophages through AEBS inhibition and lysosomal stressChiara Sfogliarini, Camilla Bernardinelli, Lien Hong Tran, et al.Bioorganic & Medicinal Chemistry Letters|June 30, 2009
Structure-Activity Relationship of novel phenylacetic CXCR1 inhibitorsManolo Rocco Sablone, Maria Candida Cesta, Alessio Moriconi, et al.Cells|March 11, 2023
Differential Effects of Nonsteroidal Anti-Inflammatory Drugs in an In Vitro Model of Human Leaky GutMichele d'Angelo, Laura Brandolini, Mariano Catanesi, et al.Journal of Medicinal Chemistry|August 2, 2007
Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2Alessio Moriconi, Maria Candida Cesta, Maria Neve Cervellera, et al.Journal of Medicinal Chemistry|June 25, 2005
2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitorsMarcello Allegretti, Riccardo Bertini, Maria Candida Cesta, et al.Cell Death & Disease|May 25, 2022
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variantsDaniela Iaconis, Licia Bordi, Giulia Matusali, et al.Pageof 2